Abstract:The synthesis of a range of 3-hydroxy-4(1H)-pyridinones with potential for the chelation of iron(III) is described. The pK(a) values of respective ligands and the stability constants of their iron(III) complexes are presented, The distribution coefficient values of a range of 48 hydroxypyridinones and their corresponding iron(III) complexes between l-octanol and MOPS buffer (pH 7.4) are reported. The range of log D-complex values covers 7 orders of magnitude. The results suggest the existence of a biphasic relationship between the distribution coefficient values of the chelator and the corresponding iron(III) complexes. For ligands with a log D-ligand = -1, a linear relationship exists with a value of the slope 2.53, whereas with ligands with a log D-ligand < -1, a linear relationship exists with a slope of 0.49. The reduced slope for the more hydrophilic molecules of the series offers some advantage for this type of hydroxypyridinone as the distribution coefficients for such complexes do not change so rapidly with increasing ligand hydrophilicity. The ability of selected 3-hydroxypyridinones to facilitate the excretion of iron in bile was investigated in non-iron-overloaded, bile duct-cannulated rats and in a [Fe-59]ferritin-loaded rat model. Both systems compare the ability of chelators to remove iron from the liver, the prime target organ in thalassemia. The N-(hydroxyalkyl)-3-hydroxypyridin-4-ones are demonstrated to be orally active under the in vivo conditions adopted. Thus both 1-(hydroxyalkyl)- and 1-(carboxyalkyl)pyridinones are able to remove iron from the liver. Although 1-(carboxyalkyl)hydroxypyridinones are active, they do not demonstrate any clear advantage over Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one). Indeed 1-(hydroxyalkyl)hydroxypyridinones which are known to be rapidly converted to 1-(carboxyalkyl)hydroxypyridinones are also marginally superior to Deferiprone. In contrast, 2-ethyl-1-(2'-hydroxyethyl)-3-hyaroxypyridin-4-one, which is not metabolized to the corresponding (carboxyalkyl)hydroxypyridinone, was found to be superior to Deferiprone and therefore deserves further consideration as an orally active iron chelator with potential for the treatment of iron overload associated with transfusion-dependent thalassemia.

Synthesis of Deferasirox,an Iron Chelator

Synthesis of deferasirox, an iron chelator

Synthesis of Deferiprone

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

Investigation on the synthesis of 25-hydroxycholesterol.

Deferasirox-TAT(47–57) peptide conjugate as a water soluble, bifunctional iron chelator with potential use in neuromedicine

Synthesis, Physicochemical Properties, and Evaluation of<i>N</i>-Substituted-2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones<sup>†</sup>

Design and Synthesis of Novel Pegylated Iron Chelators with Decreased Metabolic Rate

New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis

CN128: A New Orally Active Hydroxypyridinone Iron Chelator.

Synthesis, Characterization and Dissolution of Three Pharmaceutical Cocrystals Based on Deferiprone

In vitro studies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

Design of a water-soluble chitosan-based polymer with antioxidant and chelating properties for labile iron extraction

A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine

From Small Deferiprone to Macromolecular Micelles: Self-assembly Enhances Iron Chelation.

A Small Molecular “albumin Hitchhiking” Deferoxamine Conjugate Improved Iron Clearance Efficacy

Design and Synthesis of N-hydroxyalkyl Substituted Deferiprone: a Kind of Iron Chelating Agents for Parkinson's Disease Chelation Therapy Strategy

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

Iron Chelator Deferasirox Rescued Mice from Fas‐induced Fulminant Hepatitis

Synthesis of a Key Intermediate for Ursodeoxycholic Acid

Tuning the Solid- and Solution-State Fluorescence of the Iron-Chelator Deferasirox